Aberrant cell fusion may initiate cancerous processes and tumor formation, shows a new study from the University of Michigan's department of internal medicine. The results explain how fusion of one normal cell with other triggers a "genomic catastrophe" that converts normal cells to cancer cells and enables tumors to form.
The study provides the missing link between single cell fusion and multiple catastrophic genetic changes that transform normal cells into cancerous cells.
World's First Skull and Scalp Transplant Plus Multi-Organ Transplant on Cancer Patient
The 15-hour surgery was performed by about 50 health care professionals from Houston Methodist Hospital and the University of Texas MD Anderson Cancer Center.
Advertisement
"We believe one cell fusion event can both initiate malignancy and fuel evolution of the tumor that ensues," said lead author Xiaofeng Zhou from the University of Michigan's department of internal medicine.
Researchers studied rat IEC-6 intestinal epithelial cells because such cells maintain a stable diploid genomic structure -- two sets of chromosomes lack the cellular characteristics of cancer cells and replicate normally.
![Tools for Social Networking Analysis can Help Detect Different Types of Cancer]( "Tools for Social Networking Analysis can Help Detect Different Types of Cancer")
The tools of Social Network Analysis (SNA) unravel the connections and identify the bio-markers present in patient genomic micro-array data.
When fused IEC-6 cells were transplanted into immunodeficient mice, aberrant cells formed tumors.
Over the course of 12 weeks, these cells generated tumors in 61% (11/18) of the hosts whereas no tumors formed from the parental IEC-6 cells or IEC-6 cells that did not fuse.
Cell fusion has been postulated as a possible cause for some cancers because it could explain the occurrence of multiple genetic changes thought to underlie cancer.
The accumulation of spontaneous genetic changes, or mutations, that occur when cells divide can be quickened by exposure to carcinogens such as cigarette smoke in the case of lung cancer and infectious agents such as the papillomavirus cervical cancer.
The study appeared in the American Journal of Pathology.
Source: IANS
Tools for Social Networking Analysis can Help Detect Different Types of Cancer
The tools of Social Network Analysis (SNA) unravel the connections and identify the bio-markers present in patient genomic micro-array data.
Advertisement
When fused IEC-6 cells were transplanted into immunodeficient mice, aberrant cells formed tumors.
Over the course of 12 weeks, these cells generated tumors in 61% (11/18) of the hosts whereas no tumors formed from the parental IEC-6 cells or IEC-6 cells that did not fuse.
Cell fusion has been postulated as a possible cause for some cancers because it could explain the occurrence of multiple genetic changes thought to underlie cancer.
The accumulation of spontaneous genetic changes, or mutations, that occur when cells divide can be quickened by exposure to carcinogens such as cigarette smoke in the case of lung cancer and infectious agents such as the papillomavirus cervical cancer.
The study appeared in the American Journal of Pathology.
Source: IANS
Live Surgical Workshop in Gurgaon For Top Surgeons To Improve Cancer Treatment In India
The daylong workshop emphasized the usage of endoscope techniques for cancer treatment, which are considered to have a lower risk than other procedures.
Advertisement
 Breast Cancer Screening With Mammography Curbs Death Risk by Nearly 40%Breast screening is a vital tool in increasing early diagnosis of breast cancer among women around the world and hence reducing the number of cancer deaths. | Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
New combination of medications trametinib and entinostat were found to decrease lung cancer in mice.
Combination treatment with TALZENNA and XTANDI was found to benefit prostate cancer patients, revealed study.
In leukemia patients, reduced amounts of dietary vitamin A is associated with a higher risk and severity of pancreatitis.